The Albemarle Corporation submitted IL 141905 on 8 March 2001, as the National Phase of PCT/IL1999/020848 which published as WO2000014125 and claims priority from three separate US applications: 09/151194 from 10 September 1998, US 09/151193 from 10 September 1998 and US 09/170487 from 13… Read More ›
Israel Patent Agency
Yosef Shir submitted a patent application for a “roll stecl”. As far as I can make out from the Hebrew, this may be a roll up suckah. The Application was submitted on 16 March 2011 and the file was closed… Read More ›
Tnuva vs. Strauss – Can an Interim Decision not to Allow an Amendment to an Opposed Patent be Appealed by Right Prior to the Main Ruling Issuing?
This Supreme Court Ruling clarifies that interim rulings regarding amendments to the application within the framework of an Opposition proceedings, are part of the opposition proceedings and can only be appealed immediately if authorization to appeal is given. After the… Read More ›
This case relates to a request to revive an abandoned Application, where the Agent of Record was under the impression that he was instructed to abandon, and thus failed to respond to the office action and to the Notice of… Read More ›
Patent Application IL 201320 to Pfizer is titled “CRYSTALLINE FORMS OF 6-[2- (METHYLCARBAMOYL) PHENYLSULFANYL]-3- E -[2- (PYRIDIN2- YL] ETHENYL] INDAZOLE SUITABLE FOR THE TREATMENT OF ABNORMAL CELL GROWTH IN MAMMALS”. On allowance, it published for Opposition purposes, and Unipharm submitted… Read More ›
The Manufacturers Association of Israel opposed an ex-partes decision to allow a patent term extension for Dexlansoprazole, and New Commissioner Ofer Alon has disallowed the extension accepted by his predecessor. Background Dexlansoprazole is used for treating gastro-reflux and for treating… Read More ›